What does BIOMEDECINE do?

BIOMEDECINE is a wholesaler in Vilvoorde. Private Limited, started on 9 January 1985, 1 establishment.

What is the address of BIOMEDECINE?

The registered office of BIOMEDECINE is located at Amazonenlaan 3, 1800 Vilvoorde.

Is BIOMEDECINE still active?

Yes. According to the CBE (31 October 2026) BIOMEDECINE is active, legal situation “Normale toestand”, started on 9 January 1985.

Is BIOMEDECINE registered on Peppol?

Yes, BIOMEDECINE is registered on the Peppol network with ID 0208:0426653609.

What is the enterprise number of BIOMEDECINE?

The enterprise number of BIOMEDECINE is BE0426653609.

When was BIOMEDECINE founded?

BIOMEDECINE was founded on 9 January 1985.

Is BIOMEDECINE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 January 1985; 5 annual accounts filed, latest fiscal year 2025.

How much profit did BIOMEDECINE make in 2025?

BIOMEDECINE recorded a loss after taxes of € 8,581 in financial year 2025.

What is the revenue of BIOMEDECINE?

As a small company, BIOMEDECINE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -6,132.

BIOMEDECINE (Private Limited) - Vilvoorde - BE0426653609

Dossier BIOMEDECINE, printed on 31 October 2026 from databakkes.be/en/0426653609/biomedecine. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BIOMEDECINE from Vilvoorde, company number BE0426653609, closed financial year 2025 with a result of € -8,581 after tax. For that financial year BIOMEDECINE recorded a gross margin of € -6,132 and equity of € 14,468. Compared with financial year 2024, the result moved from € 774 to € -8,581. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.

What it is worth Healthy

€ 14,468

▼ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -8,581

▼ still € 774 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 7,078

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -4,124.

People and assets in 2025

Vehicles and equipment

€ 257

▼ 50% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 12,300

▼ 15% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 589

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,499 Gross margin 2022: € 2,499 First fiscal year in the series	€ 2,331 Gross margin 2023: € 2,331 ▼ 7% vs 2022 (€ 2,499) Unfavourable step	€ 3,522 Gross margin 2024: € 3,522 ▲ 51% vs 2023 (€ 2,331) Favourable step	€ -6,132 Gross margin 2025: € -6,132 ▼ € 9,654 vs 2024 (€ 3,522) Unfavourable step	▼ € 9,654
Profit after taxes	€ -376 Profit after taxes 2022: € -376 First fiscal year in the series	€ -358 Profit after taxes 2023: € -358 ▲ € 18 vs 2022 (€ -376) Favourable step	€ 774 Profit after taxes 2024: € 774 ▲ € 1,132 vs 2023 (€ -358) Favourable step	€ -8,581 Profit after taxes 2025: € -8,581 ▼ € 9,355 vs 2024 (€ 774) Unfavourable step	▼ € 9,355
Equity	€ 22,633 Equity 2022: € 22,633 First fiscal year in the series	€ 22,275 Equity 2023: € 22,275 ▼ 2% vs 2022 (€ 22,633) Unfavourable step	€ 23,049 Equity 2024: € 23,049 ▲ 3% vs 2023 (€ 22,275) Favourable step	€ 14,468 Equity 2025: € 14,468 ▼ 37% vs 2024 (€ 23,049) Unfavourable step	▼ 37%
Total debts	€ 36,878 Total debts 2022: € 36,878 First fiscal year in the series	€ 26,829 Total debts 2023: € 26,829 ▼ 27% vs 2022 (€ 36,878) Favourable step	€ 14,500 Total debts 2024: € 14,500 ▼ 46% vs 2023 (€ 26,829) Favourable step	€ 12,889 Total debts 2025: € 12,889 ▼ 11% vs 2024 (€ 14,500) Favourable step	▼ 11%
Cash	€ 55 Cash 2022: € 55 First fiscal year in the series	€ 293 Cash 2023: € 293 ▲ € 238 vs 2022 (€ 55) Favourable step	€ 17,385 Cash 2024: € 17,385 ▲ € 17,092 vs 2023 (€ 293) Favourable step	€ 7,078 Cash 2025: € 7,078 ▼ 59% vs 2024 (€ 17,385) Unfavourable step	▼ 59%
Retained profit	€ 4,041 Retained profit 2022: € 4,041 First fiscal year in the series	€ 3,683 Retained profit 2023: € 3,683 ▼ 9% vs 2022 (€ 4,041) Unfavourable step	€ 4,457 Retained profit 2024: € 4,457 ▲ 21% vs 2023 (€ 3,683) Favourable step	€ -4,124 Retained profit 2025: € -4,124 ▼ € 8,581 vs 2024 (€ 4,457) Unfavourable step	▼ € 8,581
Bank debt	€ 36,878 Bank debt 2022: € 36,878 First fiscal year in the series	€ 26,651 Bank debt 2023: € 26,651 ▼ 28% vs 2022 (€ 36,878) Favourable step	€ 14,500 Bank debt 2024: € 14,500 ▼ 46% vs 2023 (€ 26,651) Favourable step	€ 12,300 Bank debt 2025: € 12,300 ▼ 15% vs 2024 (€ 14,500) Favourable step	▼ 15%
Balance sheet total	€ 59,511 Balance sheet total 2022: € 59,511 First fiscal year in the series	€ 49,104 Balance sheet total 2023: € 49,104 ▼ 17% vs 2022 (€ 59,511) Unchanged	€ 37,549 Balance sheet total 2024: € 37,549 ▼ 24% vs 2023 (€ 49,104) Unchanged	€ 27,357 Balance sheet total 2025: € 27,357 ▼ 27% vs 2024 (€ 37,549) Unchanged	▼ 27%

Key figures of BIOMEDECINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BIOMEDECINE?

What happened at BIOMEDECINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 23, 2026 New annual accounts for financial year 2025: loss of € 8,581 (▼ € 9,355 vs 2024). Source: NBB ↗
Jan 9, 1985 New establishment in Jette. KBO
Jan 9, 1985 Start of the company according to the CBE. KBO

In short

From € 376 loss in 2022 to € 8,581 loss in 2025.

Paid € 2,019 in corporate taxes since 2022.

Best year ever: 2024, with € 774 profit.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Amazonenlaan 3

1800 Vilvoorde

2.026.290.903

Charles Woestelaan 69

1090 Jette

Active since 9 January 1985

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.653.609

VAT number

BE 0426.653.609

Registered office

Amazonenlaan 3, 1800 Vilvoorde

Names & denominations

BIOMEDECINE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 January 1985

Peppol

Active · Active since 22 Jan 2026

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Groothandel in farmaceutische producten

Groothandel in papier- en kartonwaren

View on CBE Public ↗ Annual accounts (NBB) ↗